依托考昔、对乙酰氨基酚、尼美舒利和布洛芬在单颗种植术后疼痛管理中的超前镇痛效果:一项随机临床试验
这项三盲、平行、随机对照临床试验纳入135例平均年龄57.6岁的患者,比较依托考昔、布洛芬、尼美舒利、对乙酰氨基酚与安慰剂在单颗种植术后超前镇痛中的效果。结果显示所有试验药物均能降低术后疼痛评分和补救药物使用量,其中依托考昔组疼痛评分显著低于其他活性药物组。布洛芬组补救药物使用平均数量最高。
要点
- 所有试验药物均提供有益的超前镇痛效果,减少术后疼痛和补救药物使用。
- 依托考昔组术后疼痛评分显著低于其他活性药物组。
- 布洛芬组补救药物使用平均数量在试验组中最高。
核心结论
- 所有试验药物均通过降低术后疼痛和减少补救药物使用表现出有益的超前镇痛效果。
- 依托考昔组疼痛评分较低,布洛芬组在试验组中补救药物使用平均数量最高。
研究设计与样本
- 三盲、平行、随机对照临床试验,纳入135例平均年龄57.6岁(±11.7)的男女患者。
- 按试验药物随机分为五组:安慰剂组、布洛芬600 mg组、尼美舒利100 mg组、对乙酰氨基酚750 mg组、依托考昔90 mg组。
主要发现
- 与安慰剂相比,试验药物降低了术后疼痛评分并减少了补救药物使用。
- 依托考昔组疼痛评分显著低于其他活性治疗组。
- 布洛芬组补救药物使用平均数量最高。
关键数值与推荐
- 布洛芬剂量600 mg,尼美舒利100 mg,对乙酰氨基酚750 mg,依托考昔90 mg。
- 疼痛发生、持续时间和强度采用卡方检验、Fisher精确检验、ANOVA及广义估计方程模型分析。
临床怎么用
- 单颗种植术后可考虑使用试验中的超前镇痛药物以减轻疼痛和减少补救药物。
- 依托考昔在降低疼痛评分方面可能优于其他试验药物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is insufficient evidence for pain control in preemptive analgesia (PA) after dental implant surgery, signaling the need for further studies. The objective of this study was to evaluate the efficacy of PA in single dental implant surgeries (SDIS), seeking to identify among the etoricoxib (ETOR), ibuprofen (IBU), nimesulide (NIME), and acetaminophen (ACETA)], which one has the higher efficacy effectiveness in relieving postoperative pain and reducing the use of rescue medication compared to placebo. METHODS: In this triple-blind, parallel, randomized controlled clinical trial, 135 individuals with a mean age of 57.6 years (±11.7), both genders, were randomly divided into five groups according to the test drug: I-PLACEBO; II-IBU (600 mg); III-NIME (100 mg); IV-ACETA (750 mg); and V-ETOR (90 mg). The occurrence, duration, and intensity of pain were analyzed using the Chi-square, Fisher's exact and ANOVA tests, and the generalized estimating equation models, when appropriate. RESULTS: Test drugs provided a reduction in postoperative pain scores and lower use of rescue medication when compared to placebo. The ETOR group presented significantly lower pain scores, when compared to other active treatments. The IBU group showed the highest mean number of rescue medication used. CONCLUSIONS: All test drugs provided a beneficial preemptive effect demonstrated by the reduced postoperative pain and reduced use of rescue medication. The ETOR group presented lower pain scores, and the IBU group showed the highest mean number of rescue medication used among the test groups.
引用
- Mattos-Pereira GH, Esteves-Lima RP, Cota LOM, et al. Preemptive effects of etoricoxib, acetaminophen, nimesulide, and ibuprofen on postoperative pain management after single-implant surgery: A randomized clinical trial. Clin Oral Implants Res. 2023. PMID: 37638406. doi:10.1111/clr.14170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。